BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 35693801)

  • 1. Conventional Type 1 Dendritic Cells in Intestinal Immune Homeostasis.
    Sasaki I; Kato T; Hemmi H; Fukuda-Ohta Y; Wakaki-Nishiyama N; Yamamoto A; Kaisho T
    Front Immunol; 2022; 13():857954. PubMed ID: 35693801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Cre-Expressing Mouse Strains Permitting to Selectively Track and Edit Type 1 Conventional Dendritic Cells Facilitate Disentangling Their Complexity
    Mattiuz R; Wohn C; Ghilas S; Ambrosini M; Alexandre YO; Sanchez C; Fries A; Vu Manh TP; Malissen B; Dalod M; Crozat K
    Front Immunol; 2018; 9():2805. PubMed ID: 30564233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical roles of a dendritic cell subset expressing a chemokine receptor, XCR1.
    Yamazaki C; Sugiyama M; Ohta T; Hemmi H; Hamada E; Sasaki I; Fukuda Y; Yano T; Nobuoka M; Hirashima T; Iizuka A; Sato K; Tanaka T; Hoshino K; Kaisho T
    J Immunol; 2013 Jun; 190(12):6071-82. PubMed ID: 23670193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crucial roles of XCR1-expressing dendritic cells and the XCR1-XCL1 chemokine axis in intestinal immune homeostasis.
    Ohta T; Sugiyama M; Hemmi H; Yamazaki C; Okura S; Sasaki I; Fukuda Y; Orimo T; Ishii KJ; Hoshino K; Ginhoux F; Kaisho T
    Sci Rep; 2016 Mar; 6():23505. PubMed ID: 27005831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine molecules targeting Xcr1 on cross-presenting DCs induce protective CD8+ T-cell responses against influenza virus.
    Fossum E; Grødeland G; Terhorst D; Tveita AA; Vikse E; Mjaaland S; Henri S; Malissen B; Bogen B
    Eur J Immunol; 2015 Feb; 45(2):624-35. PubMed ID: 25410055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD8
    Wylie B; Read J; Buzzai AC; Wagner T; Troy N; Syn G; Stone SR; Foley B; Bosco A; Cruickshank MN; Waithman J
    Front Immunol; 2018; 9():2990. PubMed ID: 30700986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging of the cross-presenting dendritic cell subsets in the skin-draining lymph node.
    Kitano M; Yamazaki C; Takumi A; Ikeno T; Hemmi H; Takahashi N; Shimizu K; Fraser SE; Hoshino K; Kaisho T; Okada T
    Proc Natl Acad Sci U S A; 2016 Jan; 113(4):1044-9. PubMed ID: 26755602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting BCL9/BCL9L enhances antigen presentation by promoting conventional type 1 dendritic cell (cDC1) activation and tumor infiltration.
    He F; Wu Z; Liu C; Zhu Y; Zhou Y; Tian E; Rosin-Arbesfeld R; Yang D; Wang MW; Zhu D
    Signal Transduct Target Ther; 2024 May; 9(1):139. PubMed ID: 38811552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of potent CD8 T cell cytotoxicity by specific targeting of antigen to cross-presenting dendritic cells in vivo via murine or human XCR1.
    Hartung E; Becker M; Bachem A; Reeg N; Jäkel A; Hutloff A; Weber H; Weise C; Giesecke C; Henn V; Gurka S; Anastassiadis K; Mages HW; Kroczek RA
    J Immunol; 2015 Feb; 194(3):1069-79. PubMed ID: 25520399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unexplored horizons of cDC1 in immunity and tolerance.
    Balan S; Radford KJ; Bhardwaj N
    Adv Immunol; 2020; 148():49-91. PubMed ID: 33190733
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Bagadia P; O'Connor KW; Wu R; Ferris ST; Ward JP; Schreiber RD; Murphy TL; Murphy KM
    J Immunol; 2021 Jul; 207(1):125-132. PubMed ID: 34135058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The In Vitro Differentiation of Human CD141+CLEC9A+ Dendritic Cells from Mobilized Peripheral Blood CD34+ Hematopoietic Stem Cells.
    Swartz AM; Nair SK
    Curr Protoc; 2022 Apr; 2(4):e410. PubMed ID: 35435334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-cell transcriptional profiling informs efficient reprogramming of human somatic cells to cross-presenting dendritic cells.
    Rosa FF; Pires CF; Kurochkin I; Halitzki E; Zahan T; Arh N; Zimmermannová O; Ferreira AG; Li H; Karlsson S; Scheding S; Pereira CF
    Sci Immunol; 2022 Mar; 7(69):eabg5539. PubMed ID: 35245086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. XCR1 expression distinguishes human conventional dendritic cell type 1 with full effector functions from their immediate precursors.
    Heger L; Hatscher L; Liang C; Lehmann CHK; Amon L; Lühr JJ; Kaszubowski T; Nzirorera R; Schaft N; Dörrie J; Irrgang P; Tenbusch M; Kunz M; Socher E; Autenrieth SE; Purbojo A; Sirbu H; Hartmann A; Alexiou C; Cesnjevar R; Dudziak D
    Proc Natl Acad Sci U S A; 2023 Aug; 120(33):e2300343120. PubMed ID: 37566635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vitro Generation of Human XCR1(+) Dendritic Cells from CD34(+) Hematopoietic Progenitors.
    Balan S; Dalod M
    Methods Mol Biol; 2016; 1423():19-37. PubMed ID: 27142006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung cDC1 and cDC2 dendritic cells priming naive CD8
    Si Y; Wang Y; Tian Q; Wang Q; Pollard JM; Srivastava PK; Esser-Kahn AP; Collier JH; Sperling AI; Chong AS
    Cell Rep; 2023 Oct; 42(10):113299. PubMed ID: 37864794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. XCR1
    Inui H; Nishida M; Ichii M; Nakaoka H; Asaji M; Ide S; Saito S; Saga A; Omatsu T; Tanaka K; Kanno K; Chang J; Zhu Y; Okada T; Okuzaki D; Matsui T; Ohama T; Koseki M; Morii E; Hosen N; Yamashita S; Sakata Y
    J Mol Cell Cardiol; 2023 Mar; 176():68-83. PubMed ID: 36739942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TIM-3 blockade enhances IL-12-dependent antitumor immunity by promoting CD8
    Gardner A; de Mingo Pulido Á; Hänggi K; Bazargan S; Onimus A; Kasprzak A; Conejo-Garcia JR; Rejniak KA; Ruffell B
    J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 34987021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8alpha+ dendritic cells.
    Crozat K; Guiton R; Contreras V; Feuillet V; Dutertre CA; Ventre E; Vu Manh TP; Baranek T; Storset AK; Marvel J; Boudinot P; Hosmalin A; Schwartz-Cornil I; Dalod M
    J Exp Med; 2010 Jun; 207(6):1283-92. PubMed ID: 20479118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are Conventional Type 1 Dendritic Cells Critical for Protective Antitumor Immunity and How?
    Cancel JC; Crozat K; Dalod M; Mattiuz R
    Front Immunol; 2019; 10():9. PubMed ID: 30809220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.